BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 29 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,260,000 | -19.6% | 400,000 | 0.0% | 0.04% | -32.7% |
| Q4 2017 | $1,568,000 | -52.4% | 400,000 | -50.0% | 0.05% | -17.5% |
| Q3 2017 | $3,296,000 | +98.6% | 800,000 | +100.0% | 0.06% | -25.0% |
| Q2 2017 | $1,660,000 | +63.4% | 400,000 | 0.0% | 0.08% | +16.7% |
| Q4 2016 | $1,016,000 | +5.4% | 400,000 | 0.0% | 0.07% | +7.5% |
| Q2 2016 | $964,000 | -9.7% | 400,000 | 0.0% | 0.07% | -28.7% |
| Q1 2016 | $1,068,000 | -41.7% | 400,000 | -50.0% | 0.09% | +28.8% |
| Q3 2015 | $1,832,000 | +26.9% | 800,000 | +100.0% | 0.07% | -16.1% |
| Q2 2015 | $1,444,000 | -18.9% | 400,000 | 0.0% | 0.09% | -37.0% |
| Q1 2015 | $1,780,000 | – | 400,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Weaver Consulting Group | 130,000 | $437,000 | 0.21% |
| Ikarian Capital, LLC | 304,161 | $1,022,000 | 0.13% |
| ABNER HERRMAN & BROCK LLC | 265,000 | $890,000 | 0.12% |
| S.C. Financial Services, Inc. | 15,285 | $51,000 | 0.06% |
| JMAC ENTERPRISES LLC | 45,430 | $153,000 | 0.04% |
| CFO4Life Group, LLC | 12,000 | $40,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 10,839 | $1,329,000 | 0.00% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 3,000 | $10,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 29,186 | $98,000 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 190,403 | $640,000 | 0.00% |